Link to this page
National Cancer Institute Thesaurus
| Preferred Name | Ceftaroline Fosamil | |
| Synonyms |
Ceftaroline Fosamil (6R,7R)-7-(((2Z)-(Ethoxyimino)(5-(phosphonoamino)-1,2,4-thiadiazol-3-yl)acetyl)amino)-3-((4-(1-methylpyridinium-4-yl)thiazol-2-yl)sulfanyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carboxylate Monoacetate Monohydrate CEFTAROLINE FOSAMIL PPI-0903 TAK-599 Teflaro |
|
| Definitions |
An N-phosphono prodrug of the fifth-generation cephalosporin derivative ceftaroline with antibacterial activity. Ceftaroline fosamil is hydrolyzed to the active form ceftaroline in vivo. Ceftaroline binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. PBPs are enzymes involved in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C81034 |
|
| CAS_Registry |
229016-73-3
|
|
| Chemical_Formula |
C22H21N8O8PS4
|
|
| code |
C81034
|
|
| Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 |
|
| Contributing_Source |
CTRP FDA
|
|
| DEFINITION |
An N-phosphono prodrug of the fifth-generation cephalosporin derivative ceftaroline with antibacterial activity. Ceftaroline fosamil is hydrolyzed to the active form ceftaroline in vivo. Ceftaroline binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. PBPs are enzymes involved in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis.
|
|
| Display_Name |
Ceftaroline Fosamil
|
|
| FDA_UNII_Code |
7P6FQA5D21
|
|
| FULL_SYN |
Ceftaroline Fosamil (6R,7R)-7-(((2Z)-(Ethoxyimino)(5-(phosphonoamino)-1,2,4-thiadiazol-3-yl)acetyl)amino)-3-((4-(1-methylpyridinium-4-yl)thiazol-2-yl)sulfanyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-2-carboxylate Monoacetate Monohydrate CEFTAROLINE FOSAMIL PPI-0903 TAK-599 Teflaro
|
|
| Has_Salt_Form | ||
| label |
Ceftaroline Fosamil
|
|
| Legacy Concept Name |
Ceftaroline_Fosamil
|
|
| NCI_Drug_Dictionary_ID |
810820
|
|
| Preferred_Name |
Ceftaroline Fosamil
|
|
| prefixIRI |
Thesaurus:C81034
|
|
| Semantic_Type |
Pharmacologic Substance
|
|
| UMLS_CUI |
C1873118
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |